These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26822118)

  • 21. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
    Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines.
    Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS
    BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential.
    Krol M; Pawlowski KM; Skierski J; Rao NA; Hellmen E; Mol JA; Motyl T
    J Physiol Pharmacol; 2009 May; 60 Suppl 1():95-106. PubMed ID: 19609018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: cell cycle modulation plus target enzyme up-regulation.
    Quan ZW; Yang Y; Li JY; Gong W; Qin YY; Li SG
    Biomed Pharmacother; 2010 Sep; 64(7):451-7. PubMed ID: 20359855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models.
    Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X
    Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of β-caryophyllene oxide and trans-nerolidol on the efficacy of doxorubicin in breast cancer cells and breast tumor-bearing mice.
    Hanušová V; Caltová K; Svobodová H; Ambrož M; Skarka A; Murínová N; Králová V; Tomšík P; Skálová L
    Biomed Pharmacother; 2017 Nov; 95():828-836. PubMed ID: 28903178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation.
    Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA
    Drug Deliv Transl Res; 2018 Oct; 8(5):1313-1334. PubMed ID: 29748834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting canine mammary tumours via gold nanoparticles functionalized with promising Co(II) and Zn(II) compounds.
    Raposo LR; Roma-Rodrigues C; Jesus J; Martins LMDRS; Pombeiro AJ; Baptista PV; Fernandes AR
    Vet Comp Oncol; 2017 Dec; 15(4):1537-1542. PubMed ID: 28150469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms.
    Gruber BM; Bubko I; Krzyszton-Russjan J; Anuszewska EL
    Med Sci Monit; 2010 Jan; 16(1):BR45-51. PubMed ID: 20037485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight.
    Rai G; Mishra S; Suman S; Shukla Y
    Phytomedicine; 2016 Mar; 23(3):233-42. PubMed ID: 26969377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of doxorubicin and retinoids on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells.
    Czeczuga-Semeniuk E; Wołczyński S; Dabrowska M; Dziecioł J; Anchim T
    Folia Histochem Cytobiol; 2004; 42(4):221-7. PubMed ID: 15704648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - The involvement of carbonyl reductase 1 inhibition.
    Piska K; Koczurkiewicz P; Wnuk D; Karnas E; Bucki A; Wójcik-Pszczoła K; Jamrozik M; Michalik M; Kołaczkowski M; Pękala E
    Chem Biol Interact; 2019 Feb; 300():40-48. PubMed ID: 30611789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic anti-cancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells.
    Sharma G; Tyagi AK; Singh RP; Chan DC; Agarwal R
    Breast Cancer Res Treat; 2004 May; 85(1):1-12. PubMed ID: 15039593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
    Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
    J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calotropis procera (Aiton) Dryand (Apocynaceae) as an anti-cancer agent against canine mammary tumor and osteosarcoma cells.
    Rabelo AC; Borghesi J; Carreira ACO; Hayashi RG; Bessa F; Barreto RDSN; da Costa RP; Cantanhede Filho AJ; Carneiro FJC; Miglino MA
    Res Vet Sci; 2021 Sep; 138():79-89. PubMed ID: 34119813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer.
    Zambrano-Estrada X; Landaverde-Quiroz B; Dueñas-Bocanegra AA; De Paz-Campos MA; Hernández-Alberto G; Solorio-Perusquia B; Trejo-Mandujano M; Pérez-Guerrero L; Delgado-González E; Anguiano B; Aceves C
    BMC Vet Res; 2018 Mar; 14(1):87. PubMed ID: 29530037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxorubicin exerts cytotoxic effects through cell cycle arrest and Fas-mediated cell death.
    Kim HS; Lee YS; Kim DK
    Pharmacology; 2009; 84(5):300-9. PubMed ID: 19829019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of metformin in mediating cellular uptake and inducing apoptosis activity of doxorubicin.
    Hoseini Shafa M; Jalal R; Kosari N; Rahmani F
    Regul Toxicol Pharmacol; 2018 Nov; 99():200-212. PubMed ID: 30266241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-influenza neuraminidase inhibitor oseltamivir phosphate induces canine mammary cancer cell aggressiveness.
    de Oliveira JT; Santos AL; Gomes C; Barros R; Ribeiro C; Mendes N; de Matos AJ; Vasconcelos MH; Oliveira MJ; Reis CA; Gärtner F
    PLoS One; 2015; 10(4):e0121590. PubMed ID: 25850034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.